Filing Details

Accession Number:
0001219036-21-000014
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-07-08 17:50:44
Reporting Period:
2021-07-07
Accepted Time:
2021-07-08 17:50:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
899923 Myriad Genetics Inc MYGN In Vitro & In Vivo Diagnostic Substances (2835) 870494517
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1219036 S Jerry Lanchbury 320 Wakara Way
Salt Lake City UT 84108
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-07-07 30,424 $26.49 262,974 No 4 M Direct
Common Stock Disposition 2021-07-07 30,424 $32.29 232,550 No 4 S Direct
Common Stock Acquisiton 2021-07-07 1,884 $26.49 234,434 No 4 M Direct
Common Stock Disposition 2021-07-07 1,884 $31.99 232,550 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Incentive Stock Option (right to buy) Disposition 2021-07-07 1,884 $0.00 1,884 $26.49
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2021-07-07 30,424 $0.00 30,424 $26.49
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2021-09-17 No 4 M Direct
141,828 2021-09-17 No 4 M Direct
Footnotes
  1. The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  2. The shares subject to this option are fully vested and exercisable.